Benjamin Shore, MD, MPH, FRCSC, is Associate Professor of Orthopedic Surgery at Harvard Medical School and a practicing pediatric orthopedic surgeon at Boston Children’s Hospital. He serves as Co-Director of the Cerebral Palsy and Spasticity Center and Director of the Pediatric Orthopaedic Surgery Fellowship. Education and Training Undergraduate: Biology, University of Victoria, 1999 MPH: Harvard School of Public Health, 2013 MD: University of Western Ontario, 2003 Residency: Orthopedic Surgery, University of Western Ontario, 2008 Fellowship 1: Pediatric Orthopedics, Royal Children's Hospital, Melbourne, 2009 Fellowship 2: Pediatric Orthopedics, Boston Children’s Hospital, 2010 Research Focus Dr. Shore’s research centers on improving outcomes for children with cerebral palsy and other complex musculoskeletal conditions. His work spans hip surveillance and reconstruction, gait abnormalities, trauma care, and the implementation of evidence-based surgical pathways. He has pioneered investigations into anesthesia protocols, infection prevention, and patient-reported outcome measures for pediatric orthopedic populations. Scientific Awards St. Giles Young Investigator Award (POSNA) Clinician Scientist Development Program Award (CSDP) Charles H. Hood Foundation Child Health Research Award Leadership & Multi-Disciplinary Teams At Boston Children’s Hospital, Dr. Shore leads a high-performance team within the Cerebral Palsy and Spasticity Center that integrates orthopedic surgery, neurology, physical therapy, and social work to deliver patient- and family-centered care. He mentors fellows and residents and actively contributes to national consensus projects using Delphi methodology to standardize surgical indications in cerebral palsy.
Jacob Young, MD, is an Assistant Professor in the Department of Neurological Surgery at the University of California, San Francisco (UCSF) School of Medicine and a Principal Investigator in the UCSF Brain Tumor Center. His clinical practice focuses on neurosurgical management of adult brain tumors including gliomas, metastatic tumors, and meningiomas, utilizing advanced brain mapping techniques to preserve critical motor, language, and sensory functions during resection. Dr. Young's educational background includes a BS in Neuroscience from Duke University (2012), an MD from the University of Chicago Pritzker School of Medicine where he was elected to Alpha Omega Alpha Honor Medical Society (2017), and a neurosurgery residency at UCSF (2017-2024). His research program integrates laboratory investigations with clinical trials to address fundamental challenges in brain tumor treatment. His primary research interests center on understanding glioblastoma immune microenvironment dynamics and developing innovative therapeutic strategies. Key focus areas include: First-in-human clinical trials of novel immunotherapies Focused ultrasound-mediated blood-brain barrier disruption to enhance drug delivery Longitudinal molecular profiling of tumor evolution during treatment AI-driven tools for patient care navigation and clinical trial assessment Prospective outcomes research through the RANO resect group and NeuroPoint Alliance His work bridges fundamental tumor biology with translational applications to overcome treatment resistance. Analysis of Dr. Young's 15 most recent publications (2023-2025) reveals a strong emphasis on surgical innovation, tumor immunology, and molecular characterization. Key trends include: development of prognostic classification systems for resection extent, investigation of glioma-neuronal circuit interactions driving immunosuppression, and optimization of drug delivery strategies. His collaborative work within the RANO consortium establishes evidence-based surgical guidelines while his lab's focus on microenvironmental factors informs next-generation immunotherapies. Dr. Young has received significant recognition including: Chan-Zuckerberg Physician Scientist Fellowship (2021-2022) ASCO Young Investigator Award (2022-2023) Andrew J. Lockhart Focused Ultrasound Fellowship (2023) Multiple Harold Rosegay Teaching Awards from UCSF Howard Naffziger Award for Clinical Excellence His research is supported by NIH, NCI, Focused Ultrasound Foundation, and AANS grants. As lab director, Dr. Young mentors a diverse team including PhD candidates like Edward Valenzuela (DSCB program) and specialists in immunology and neuro-oncology. His lab participates in the RANO resect group, ENCRAM research program, and NeuroPoint Alliance to advance clinical protocols. Current projects include developing intraoperative focused ultrasound prototypes, single-cell analysis of tumor evolution, and AI tools for patient navigation through care pathways. Future work focuses on translating microenvironment discoveries into combination therapies targeting treatment resistance mechanisms.
Ario Sadafi is a researcher at the Technical University of Munich (TUM) , affiliated with the Chair of Computer Science Applications in Medicine under Prof. Nassir Navab. His work spans medical image analysis , machine learning , and computational pathology , with a strong focus on developing AI-driven solutions for microscopic imaging in hematology and oncology. Research Focus: Multiple Instance Learning for weakly supervised medical image classification. Explainable AI for biomedical single-cell imaging. Continual and cross-domain learning for robust diagnostic models. Microscopic image analysis for blood cell disorders and leukemia subtyping. Teaching Contributions: Sadafi has been actively involved in teaching courses such as Computer Aided Medical Procedures , Medical Augmented Reality , and Deep Learning for Medical Applications . He also supervises practical courses and seminars in 3D Computer Vision and Machine Learning in Medical Imaging . Labs & Collaborations: He works closely with the MEDIA (Medical Image Analysis) and NARVIS labs at TUM, contributing to projects in surgical data science , generative models , and robotics & ultrasound . Publications Impact: His research output (2018–2025) emphasizes AI-driven hematology , with applications in red/white blood cell classification, leukemia subtype diagnosis, and interpretable deep learning models for clinical use.
Eldrin F. Lewis, MD, MPH is the Simon H. Stertzer, MD, Professor of Medicine and Chief of the Division of Cardiovascular Medicine at Stanford University School of Medicine. He holds a University Medical Line Professorship within the Department of Medicine - Cardiovascular Medicine and is a member of the Cardiovascular Institute. Dr. Lewis earned his medical degree from the Perelman School of Medicine at the University of Pennsylvania (1995), completed his Internal Medicine Residency (1998), Cardiovascular Disease Fellowship (2001), and Heart Transplant Fellowship (2002), all at Brigham and Women's Hospital in Massachusetts. He maintains board certification in Cardiovascular Disease (2024) and Advanced Heart Failure and Transplant Cardiology (2025) through the American Board of Internal Medicine. As an internationally recognized expert in heart failure, heart transplant, and quality of life for heart failure patients, Dr. Lewis' research focuses on patient-reported outcomes, quality of life assessment, and the integration of digital health technologies into cardiovascular care. His fundamental principle is that "there is more to life than death," emphasizing that cardiovascular care should help patients not only survive but also enjoy the best possible quality of life. His extensive publication record includes nearly 200 peer-reviewed articles in top journals including the New England Journal of Medicine, Journal of the American College of Cardiology, Circulation, JAMA Cardiology, and JAMA Internal Medicine. His recent work (2024-2025) demonstrates strong focus on heart failure treatment optimization, diversity in clinical trials, pulmonary congestion assessment, and the implementation of quadruple medical therapy for heart failure patients. Joel Gordon Miller Award for community service and leadership from the University of Pennsylvania School of Medicine Minority Faculty Development Award recognizing research potential of young physicians Robert Wood Johnson Foundation grant for quality of life assessment research Fellow of the American College of Cardiology Member of the American Heart Association Research Committee Dr. Lewis serves as a Postdoctoral Faculty Sponsor for Phenesse Dunlap and has received significant research support from the National Heart, Lung and Blood Institute, National Institutes of Health, and the Robert Wood Johnson Foundation. He is deeply committed to expanding clinical research initiatives at Stanford, forming partnerships with community cardiologists, and leveraging Silicon Valley's digital technology expertise for patient monitoring and treatment optimization. His leadership includes serving on the AHA Founders Affiliate Board of Directors, chairing the Council on Clinical Cardiology, and participating in the FDA Task Force for Standardization of Definitions for Endpoint Events in Cardiovascular Trials.
Panying Rong, Ph.D. is an Assistant Professor in the Department of Speech-Language-Hearing: Sciences & Disorders at the University of Kansas , within the College of Liberal Arts and Sciences. Her research focuses on the neuromechanical basis of motor speech disorders and the development of quantitative tools for speech assessment. Primary Affiliation: University of Kansas Department: Speech-Language-Hearing: Sciences & Disorders Academic Rank: Assistant Professor Email: prong@ku.edu Research Interests Dr. Rong’s work investigates the biomechanical and neurological mechanisms underlying speech impairments in neurodegenerative diseases like ALS and Parkinson’s. Key areas include: Mechanistic modeling of speech motor control Development of data-driven speech diagnostics Acoustic and kinematic analysis of bulbar disorders Compensatory articulatory strategies in speech pathologies Temporal structuring of speech signals Integration of multimodal assessments for neurological conditions Article Trends Her recent publications emphasize automated, multimodal frameworks for assessing bulbar ALS, neuromechanical biomarkers, and cultural-linguistic influences on speech outcomes. Techniques include EMA, EMG, kinematic modeling, and computational analysis of speech subsystems.
Maarten Renkema is an Assistant Professor at the University of Twente, specializing in Artificial Intelligence (AI) and its intersection with Human Resource Management (HRM) , Healthcare , and Organizational Innovation . His research explores how AI transforms work design, employee autonomy, and HRM practices in formalized contexts. Key Research Themes: Algorithmic HRM and Digitalization Human-AI Collaboration in Healthcare Self-Managing Teams and Organizational Structures AI Literacy in Education Scientific Awards: Best Dissertation Award (2019) from the Dutch HRM Network Research Trends: His recent work focuses on AI adoption in HRM, ethical implications of algorithmic management, and redefining professional roles in AI-integrated environments. Articles from 2024-2025 highlight practical applications of AI in healthcare workflows, employee-driven innovation, and the evolving responsibilities of HR professionals. Collaborations: Active in cross-sector partnerships, including projects on AI literacy frameworks and talent management in sports. Regularly contributes to professional discourse through invited talks and media commentary on AI's societal impact.
Khiet P. Truong is an Associate Professor affiliated with the Digital Society Institute and the Human Media Interaction group. Their research focuses on the intersection of artificial intelligence, robotics, and human-computer interaction, with particular emphasis on speech emotion recognition, conversational agents for children, and multimodal interaction analysis. Recent work includes exploring how robots can restore trust through apologies, benchmarking Dutch automatic speech recognition systems, and developing child-friendly interfaces for cultural heritage archives. Truong has also investigated physiological signals like laughter and stress markers in speech across diverse contexts. Scientific Awards : Best Functional Design Award (2019) Research Trends : Analysis of speech patterns, emotion recognition, robot-human dialogue, and multimodal behavioral cues dominate their recent publications. Key subfields include Dutch language processing, laughter classification, trust indicators in child-robot interactions, and healthcare applications of speech technology. Academic Activities : Chair of the 26th ACM International Conference on Multimodal Interaction (2024) Examiner roles for PhD defenses and research evaluations (2024–2023) Contributions to workshops on emotion representation and social signal processing
Dr. Richard Y. Zhao is a tenured Professor in the Department of Pathology and Microbiology-Immunology at the University of Maryland School of Medicine. His research combines molecular biology, fission yeast genetics, mammalian biology, and virology to study virus-host interactions, particularly for HIV and Zika virus. He previously held academic positions at Northwestern University and Columbia University and has contributed to over 120 peer-reviewed articles. B.S., China Oceanography University (1981) M.S., Oregon State University (1995) Ph.D., Oregon State University (1991) Postdoctoral Training, Columbia University (1991-1992) Dr. Zhao's research focuses on: Virus-host interactions and pathogenicity High-throughput drug screening for antivirals Role of viral proteins in neuroinflammation and cancer Translational genomics in precision medicine His recent publications highlight SARS-CoV-2 ORF3a, Zika envelope proteins, and HIV protease inhibitors, emphasizing host-pathogen mechanisms across species. He has served on NIH panels and editorial boards for journals like Cell Research and Retrovirology . Scientific awards include: Fellow, American Academy of Microbiology (2019) Bernard L Mirkin Endowed Chair (2001-2004) Honorary Director, Shandong Gallo Institute (2009) Distinguished Service from SCBA (2015) Outstanding Service from CBA-USA (2016) Dr. Zhao also contributes to clinical diagnostics and personalized medicine through molecular testing and pharmacogenetics programs.
Karen S. Anderson, M.D., Ph.D. is a Professor of Medicine at Mayo Clinic in Phoenix, Arizona, where she serves as a Contract Physician in the Division of Hematology/Oncology within the Department of Internal Medicine. Her clinical practice focuses on breast cancer, and she is affiliated with the Mayo Clinic Comprehensive Cancer Center and the Breast Clinic. As an active researcher, Dr. Anderson leads clinical trials in breast cancer immunotherapy and biomarker development. Dr. Anderson's educational background includes: Medical Scientist Training Program (MD), Duke University School of Medicine (1994) Ph.D. in Microbiology and Immunology, Duke University (1994) BA in Chemistry, University of Virginia (1986) Internship and Residency in Internal Medicine, Brigham and Women's Hospital, Boston Fellowship in Adult Hematology and Oncology, Dana Farber Cancer Institute Dr. Anderson's research focuses on cancer immunology with particular emphasis on breast cancer biomarkers, ovarian cancer biomarkers, pancreatic cancer biomarkers, cancer vaccines, and HPV-related cancers. Her work spans from basic immunology to clinical applications, with a strong focus on translating laboratory findings into clinical practice. She has developed innovative approaches for early cancer detection and has been instrumental in advancing breast cancer immunotherapy through clinical trials. Analysis of Dr. Anderson's recent publications reveals a consistent focus on breast cancer immunology, biomarker discovery, and HPV-related cancers. Her work integrates molecular biology, immunology, and clinical oncology to develop novel diagnostic and therapeutic approaches. Notably, her research has expanded to include computational approaches for neoantigen prediction and has addressed public health challenges including HPV-related cancer screening and even COVID-19 vaccine strategies. Dr. Anderson has received several prestigious awards: Outstanding Faculty Mentor Arizona State University Faculty Women's Association (2020) Chief Resident West Roxbury VA Hospital (1996) Phi Beta Kappa University of Virginia (1986) Merck Scholar (1986) Alpha Omega Alpha Honor Medical Society (1986) Echols Scholar University of Virginia (1982) Dr. Anderson has been actively involved in mentoring students and early-career researchers, serving on numerous thesis committees at Arizona State University across multiple departments including Molecular and Cellular Biology, Chemistry, and the Barrett Honors College. Her research is supported by multiple grants from the National Cancer Institute, including her role as Co-Chair of the Breast and Gynecologic Cancers Collaborative Group within the Early Detection Research Network. Dr. Anderson is a key member of the Arizona Biomarker Alliance Executive Committee and has established collaborative research teams focused on cancer biomarker discovery and validation. Her laboratory work integrates protein microarray technology, immunology, and cancer genomics to develop novel diagnostic and therapeutic approaches for breast and HPV-related cancers.
Kuo-Fen Lee, PhD is a Professor at the Salk Institute for Biological Studies, holding the prestigious Helen McLoraine Chair of Molecular Neurobiology. He leads the Clayton Foundation Laboratories for Peptide Biology, where his research focuses on nerve regeneration, spinal cord injury, and molecular mechanisms underlying neural development and neurodegenerative diseases. His work bridges basic neuroscience with potential therapeutic applications for conditions like ALS, paralysis, and Alzheimer's disease. Dr. Lee received his educational training from multiple prestigious institutions: a degree in Plant Pathology from National Taiwan University; an MS in Cancer Enzymology and Cell Differentiation from National Yang-Ming Medical College, Taiwan; a PhD in Endocrinology from Baylor College of Medicine, Houston; and completed his postdoctoral training at the Whitehead Institute for Biomedical Research. His primary research interests center on understanding why humans cannot regenerate damaged nerves while many other animals can. Dr. Lee has made significant discoveries regarding the p45 protein, which promotes nerve regrowth in mice but is absent in humans (who instead have p75, which inhibits nerve growth). His laboratory also studies neuregulin signaling, neuromuscular synapse formation, and the role of various proteins like nestin in neural development and maintenance. His work often employs mouse models to investigate spinal cord injury, pain pathways, and neurodegenerative conditions. Analysis of Dr. Lee's recent publications reveals a consistent focus on molecular neurobiology with particular emphasis on neural signaling pathways, synaptic maintenance, and nerve regeneration mechanisms. His research spans from basic molecular mechanisms to potential therapeutic applications, with increasing attention to pain pathways, Alzheimer's disease models, and the intersection of neuroscience with immunology and metabolism in recent years. As holder of the Helen McLoraine Chair of Molecular Neurobiology, Dr. Lee has received significant institutional recognition for his contributions to neuroscience. While specific awards aren't detailed in the provided text, his sustained funding and leadership position indicate substantial peer recognition in his field. Dr. Lee's research program involves extensive collaboration with other neuroscience laboratories, as evidenced by his numerous co-authored publications across various neuroscience subdisciplines. His work has been consistently funded, allowing for the maintenance of an active research laboratory focused on nerve regeneration and molecular neurobiology. The Clayton Foundation Laboratories for Peptide Biology serves as the primary research environment for Dr. Lee's team, where they investigate molecular mechanisms of nerve development, regeneration, and degeneration using advanced genetic, molecular, and cellular approaches. The laboratory maintains active research programs in multiple areas of neural signaling and development.
Dr. Mohamed Khalifa is a Visiting Fellow at the Centre for Health Informatics, Australian Institute of Health Innovation, Macquarie University, Sydney. He holds a PhD in Health Innovation from Macquarie University (2020) and an MSc in Health Informatics from the University of Edinburgh (2012). His expertise spans health informatics, AI-driven healthcare solutions, and strategic healthcare management. He has led multidisciplinary teams in developing evidence-based frameworks like GRASP for clinical predictive tools. Affiliations: Visiting Fellow, Macquarie University Director of Studies, College of Health Sciences (Education Centre of Australia) Former Digital Health Officer, Australian Digital Health Agency (2020–2021) His research focuses on AI applications in healthcare, clinical decision support systems, and health analytics. Over 20 years, he has published 60+ peer-reviewed papers and holds an innovation patent (2018). He has received awards including the IMIA Best Paper (2020) and ICIMTH Best Paper (2015). Dr. Khalifa’s work emphasizes improving healthcare efficiency through technology, including projects on predictive tools, emergency room performance, and diabetes management. He is a Fellow of the Australasian Institute of Digital Health and certified in healthcare information systems (CPHIMS).
Roxanne Wadia, MD, holds dual roles as a Clinical Fellow in Pathology and Clinical Assistant Professor of Medicine (Medical Oncology) at Yale School of Medicine. Her expertise spans anatomic and cytopathology, with a focus on cancer diagnosis and treatment guidance. She completed her medical degree at Vanderbilt University School of Medicine (2008) and is board-certified in Anatomic Pathology (2023) and Cytopathology (2024). Dr. Wadia’s research integrates oncology, HIV/AIDS, and medical informatics, leveraging large datasets such as the VA’s Million Veterans Program to improve cancer care outcomes. She actively contributes to clinical care at Yale New Haven Hospital, the VA Connecticut Healthcare System, and the Hospital of Saint Raphael’s, emphasizing holistic patient care and interdisciplinary collaboration. Her research explores prostate cancer prognosis, HIV-related malignancies, and healthcare analytics. Key projects include developing predictive tools for nonmetastatic prostate cancer mortality and studying lung cancer surgery outcomes in HIV-positive patients. Dr. Wadia also mentors trainees in oncology and hematology, emphasizing independent clinical decision-making. She participates in the VA’s clinical training programs for medical students, residents, and fellows, fostering a balance between clinical practice and research innovation.
Dr. Vahid Hosseini is an Associate Professor and Graduate Program Chair in the School of Sustainable Energy Engineering at Simon Fraser University (SFU). His research focuses on sustainable energy systems, urban air pollution, and clean mobility solutions. He holds a Ph.D. in Mechanical Engineering from the University of Alberta (2008), and M.A.Sc. and B.Eng. degrees from Sharif University of Technology (Iran). His academic roles include leadership in graduate academic programs and engineering education. Key research areas include thermo-fluid systems analysis, vehicle emissions reduction, and urban air quality modeling. He is actively involved in projects addressing real-world driving emissions, emission inventory development, and the impact of cold climates on transportation energy consumption and pollution. Notable contributions include studies on retrofit emission control devices for motorcycles, high-emitter vehicle identification, and policy recommendations for emission reduction. His work integrates experimental methods, computational fluid dynamics (CFD), and machine learning to tackle complex environmental challenges. Teaching interests span thermodynamics, fluid mechanics, and air pollution control engineering. Current courses include SEE 325 D100 Mechanical Design and Finite Element Analysis . Research highlights include collaborations on Tehran’s air quality management, particulate matter (PM2.5) source apportionment, and the development of high-resolution emission inventories. He contributes to international conferences and journals, with a focus on practical solutions for sustainable urban transportation systems.
Dr. Hongli (Julie) Zhu is an Associate Professor in the Department of Mechanical and Industrial Engineering at Northeastern University's College of Engineering. Her research focuses on sustainable energy storage, multifunctional materials, and advanced manufacturing, with emphasis on developing environmentally friendly biomass-derived materials, all solid-state batteries, and flow batteries. She leads the ZHU Lab at Northeastern University, which is dedicated to creating safer, cheaper, and higher performance energy storage solutions while exploring multifunctional materials derived from nature. Dr. Zhu received her PhD from South China University of Technology and Western Michigan University (2004-2009). She conducted postdoctoral research at KTH Royal Institute of Technology in Sweden (2009-2011), focusing on biodegradable and renewable biomaterials from natural wood, followed by additional postdoctoral work at the University of Maryland (2012-2015), where she researched nanocellulose and energy storage. Dr. Zhu's research spans multiple disciplines at the intersection of materials science, energy storage, and sustainable manufacturing. Her work addresses critical challenges in energy storage technology, including developing all solid-state batteries, flow batteries, and high energy density battery systems. She has pioneered research in sustainable biomass-derived materials, particularly investigating cellulose, hemicellulose, and lignin for applications in bendable, implantable, and biocompatible electronics. Her lab also focuses on advanced manufacturing techniques, including high-speed roll-to-roll processing for emerging advanced materials and devices. Analysis of Dr. Zhu's publication record reveals a strong focus on next-generation battery technologies, particularly solid-state systems. Her research demonstrates significant contributions to understanding and improving lithium dendrite suppression, electrode architecture optimization, and interface stabilization in solid-state batteries. She has also made substantial advances in sustainable materials derived from natural resources, developing applications for cellulose nanostructured fibers, paper, and aerogel/hydrogel systems. MRS Communications Early Career Distinguished Presenters and JMR Distinguished Invited Speakers (2024) Selected in Stanford University List of Top 2% Scientists Worldwide (2021-2024) College of Engineering Faculty Fellow (2023) Soren Buus Outstanding Research Award (2022) Women in Materials Science, Advanced Materials (2021 and 2022) Women Scientists at the Forefront of Energy Research, ACS Energy Letters (2020) Innovator of the Year 2013, Maryland Jakob Wallenberg Scholarship, Sweden Dr. Zhu has secured significant research funding from various sources, including the National Science Foundation and Department of Energy. Her current projects include "Uncovering the mechano-electro-chemo mechanism of fresh Li in sulfide based all solid-state batteries through operando studies" (NSF), "Enabling Advanced Electrode Architecture through Printing Technique" (DOE), and "Engineering the Metal Sulfide Interface in All Solid State Batteries through Operando Study" (NSF). She collaborates with industry partners including Rogers Corporation and has developed patented technologies related to sustainable materials and energy storage. Dr. Zhu serves as Codirector of Advanced & Intelligent Manufacturing, Editor of Progress in Materials Science, and on the Editorial Advisory Board of Chemical Society Reviews. The ZHU Lab at Northeastern University is a highly interdisciplinary research group that bridges scales from the nanoscopic to macroscopic and system level. The lab's work has led to numerous patents, including "Natural fiber composites as a low-cost plastic alternative" and "Fire-retardant Nanocellulose Aerogel, and Methods of Preparation and Uses Thereof." The group focuses on making energy storage safer, cheaper, and higher performing while exploring multifunctional materials derived from nature, with particular emphasis on applying high-speed roll-to-roll manufacturing to emerging advanced materials and devices.
Professor Jerome Liang is a distinguished faculty member at Stony Brook University's Renaissance School of Medicine, holding professorships in Radiology, Biomedical Engineering, Electrical and Computer Engineering, and Computer Science. He serves as Co-Director of Radiology Research and has established himself as a leading expert in medical imaging reconstruction techniques. Dr. Liang's educational background includes a Ph.D. in Physics from City University of New York, postdoctoral training at Duke University, and fellowship at Albert Einstein College of Medicine. His undergraduate degree in Modern Physics was obtained from Lanzhou University in China. His primary research interests focus on advanced medical imaging techniques, particularly low-dose computed tomography image reconstruction, quantitative SPECT reconstruction, high-resolution PET imaging, tissue segmentation from multi-spectral images, computer-aided diagnosis systems, and virtual colonoscopy development. His work bridges engineering principles with clinical applications to improve diagnostic imaging capabilities while reducing radiation exposure. Analysis of his recent publications reveals a strong focus on machine learning applications in medical imaging, particularly in polyp classification, dual-energy CT spectral analysis, and virtual endoscopy. His research consistently aims to enhance diagnostic accuracy while optimizing radiation dose and improving visualization techniques for various medical conditions. 1981 China-US Physics Examination and Application Program (CUSPEA) Winner (Top 25 among 250,000 candidates) 1990 NIH First Investigator Award 1996 American Heart Association Established Investigator Award 1996 Radiological Society of North America Certificate of Merit Award 2002 SUNY Chancellor's Entrepreneur Award 2007 IEEE Society Fellow 2011-2013 SBU, BNL and CSHL Certificates of Excellence in Research and Invention 2013 Stony Brook School of Medicine Award for Excellence in Translational Research Dr. Liang has secured significant research funding including NIH/NCI R01 grants for "Advanced Virtual Colonoscopy for Early Cancer Screening" and "Radiogenomics of Colorectal Polyps." He currently leads active protocols including IRB 93995-MODCR005 focused on integrating virtual and optical colonoscopies with pathological analysis. His laboratory (IRIS - Imaging Research and Informatics) continues to advance medical imaging technology while mentoring the next generation of researchers in this critical field.
